Scarica l'app Stockscreener
45.69
1.58%
0.71
Dopo l'orario di chiusura:
45.69
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$44.98
Aprire:
$45.09
Volume 24 ore:
1.51M
Relative Volume:
0.71
Capitalizzazione di mercato:
$6.96B
Reddito:
$3.46B
Utile/perdita netta:
$-9.40M
Rapporto P/E:
-190.06
EPS:
-0.2404
Flusso di cassa netto:
$51.30M
1 W Prestazione:
+6.55%
1M Prestazione:
+15.18%
6M Prestazione:
-3.34%
1 anno Prestazione:
+25.73%
Intervallo 1D:
$45.02
$45.90
Intervallo di 1 settimana:
$41.62
$45.90
Portata 52W:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Nome
Bruker Corp
Settore
Industria
Telefono
978663-3660
Indirizzo
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
45.69 | 6.85B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Iniziato | Goldman | Sell |
| 2025-11-20 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-10-15 | Iniziato | Barclays | Overweight |
| 2024-09-30 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2022-10-21 | Iniziato | UBS | Buy |
| 2022-08-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Iniziato | Goldman | Sell |
| 2020-11-16 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Downgrade | Needham | Strong Buy → Hold |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-24 | Reiterato | Needham | Strong Buy |
| 2019-06-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
| 2019-05-06 | Reiterato | Needham | Strong Buy |
| 2019-05-03 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Aggiornamento | UBS | Sell → Neutral |
| 2019-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Reiterato | BTIG Research | Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
Mostra tutto
Bruker Corp Borsa (BRKR) Ultime notizie
Bruker Corporation (BRKR) Stock Analysis: Exploring a 7.58% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corporation 8-K SEC Filing Summary – Company Information, Address, and Securities Details (May 21, 2026) - Minichart
Bruker stockholders elect directors and approve proposals at annual meeting - Investing.com
Bruker (NASDAQ: BRKR) investors back board slate and auditor at 2026 meeting - Stock Titan
Bruker Corp Annual Shareholders Meeting Transcript - GuruFocus
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
A Look at Bruker Corp (BRKR) After 3.9% Gain -- GF Value $62.37 vs Price $44.27 - GuruFocus
Thrivent Financial for Lutherans Acquires 152,603 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker (BRKR) director receives 2,886 RSUs vesting in 2027 - Stock Titan
Bruker (NASDAQ: BRKR) EVP exercises options and sells 2,000 shares under plan - Stock Titan
BRKR Technical Analysis | Trend, Signals & Chart Patterns | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker Corp stock (US1167941087): upbeat guidance and life-science demand support growth story - AD HOC NEWS
[8-K] BRUKER CORP Reports Material Event - Stock Titan
2,000-share proposed sale via option exercise (BRKR) reported - Stock Titan
Orbis group discloses 11.8% stake in Bruker Corp (BRKR) - Stock Titan
Bruker (NASDAQ:BRKR) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Bruker Corp (BRKR) Stock Price, Trades & News - GuruFocus
Assessing Whether Bruker (BRKR) Looks Undervalued After Recent Share Price Momentum - Yahoo Finance
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Moomoo
Wall Street Zen Upgrades Bruker (NASDAQ:BRKR) to Buy - MarketBeat
Stifel Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - Moomoo
Bruker Corp. Opens with a 10.16% Gain, Outperforming S&P 500's 1.46% Rise - Markets Mojo
Bruker Corporation (NASDAQ:BRKR) Q1 2026 Earnings Call Transcript - Insider Monkey
Bruker Corp. Hits Day High with 11.29% Surge in Stock Price - Markets Mojo
Bruker Price Target Raised to $45.00/Share From $43.00 by TD Cowen - Moomoo
UBS Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - 富途牛牛
Bruker Is Maintained at Hold by TD Cowen - Moomoo
BRKR Financials: Income Statement, Balance Sheet & Cash Flow | Bruker Corp - Stock Titan
Bruker (NASDAQ: BRKR) Q1 2026 revenue reaches $823M amid restructuring - Stock Titan
UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating - Moomoo
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $44 to $53 - 富途牛牛
UBS Group AG Lowers Stock Holdings in Bruker Corporation $BRKR - MarketBeat
BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down - Yahoo Finance
BRUKER ($BRKR) Releases Q1 2026 Earnings - Moomoo
TD Cowen Initiates Bruker Corp(BRKR.US) With Hold Rating, Announces Target Price $45 - 富途牛牛
How many employees work at Bruker Optics? - Revelio Labs
BRUKER CORPORATION (BRKR) - MSN
Bruker Q1 Adjusted Earnings Fall, Revenue Rises; Maintains Fiscal 2026 Outlook - Moomoo
Bruker Q1 2026 slides: beats estimates despite organic revenue decline - Investing.com
FMR LLC boosts stake in Bruker (NASDAQ: BRKR) to 12.4% - Stock Titan
Bruker Q1 Earnings Call Highlights - Yahoo Finance
Bruker (NASDAQ:BRKR) Shares Gap Up on Strong Earnings - MarketBeat
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises - Investing.com
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Canada
Opportunity Insights for the $1.1 Billion Preclinical Imaging Industry, 2026Bruker Corp., Cubresa, and Siemens Healthineers Lead - Yahoo Finance UK
Full Transcript: Bruker Q1 2026 Earnings CallBruker (NASDAQ:BRKR) - Benzinga
Q1 2026 Bruker Corp Earnings Call Transcript - GuruFocus
Bruker (NASDAQ:BRKR) Beats Q1 Estimates but Maintains Cautious Full-Year Guidance Amid Organic Revenue Decline - ChartMill
Bruker shares rise 4% on first quarter earnings beat - Investing.com
Bruker shares rise 4% on first quarter earnings beat By Investing.com - Investing.com Canada
Bruker Corp Azioni (BRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.22%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):